期刊文献+

IGF1R和IGFBP3在肺鳞癌中的表达及其临床意义 被引量:5

Expressions and clinical significances of IGF1R and IGFBP3 in squamous cell lung cancer
下载PDF
导出
摘要 目的:检测IGF1R、IGFBP3在肺鳞癌组织中的表达,并探讨其在肺鳞癌发生发展中的作用及其临床意义。方法:用免疫组化二步法检测246例肺鳞癌术后组织与40例癌旁正常组织中IGF1R、IGFBP3的表达情况,并分析二者的相关性及与临床病理特征和预后的关系。结果:IGF1R在肺鳞癌组织中的阳性表达明显高于癌旁正常组织,其表达率分别为54.07%、32.5%,IGFBP3在肺鳞癌组织中的阳性表达明显低于癌旁正常组织,其表达率分别为61.79%、87.5%,差异具有统计学意义(P<0.05)。IGF1R的表达与淋巴结转移正相关(P<0.05),IGFBP3的表达与肺癌的TNM分期、淋巴结转移负相关(P<0.01),而与其他临床病理参数无关(P>0.05)。IGF1R阳性表达组患者生存期明显短于IGF1R阴性表达组患者,IGFBP3阳性表达组患者生存期明显长于IGFBP3阴性表达组患者,差异有统计学意义(P分别为<0.001和=0.001)。Cox单因素分析显示TNM分期、淋巴结转移、IGF1R及IGFBP3的表达均与预后相关,将TNM分期、淋巴结转移、IGF1R及IGFBP3的表达进行Cox回归多因素分析,结果显示TNM分期、IGF1R及IGFBP3的表达均为肺鳞癌患者的独立预后因子。IGF1R、IGFBP3在肺鳞癌组织中表达呈负相关(r=-0.204,P<0.001)。结论:IGF1R、IGFBP3参与了肺鳞癌的发生、发展,并且二者均为肺鳞癌的独立预后因子。有望成为分子靶向治疗的新靶点。 Objective: To detect the expression of IGF1 R,IGFBP3 in resected squamous cell lung cancer( SQCLC) tissue and to explore the correlation of IGF1 R,IGFBP3 with SQCLC occurrence,development. Methods: All246 cases of resected squamous cell lung cancer and 40 cases of adjacent cancer normal tissue were detected for IGF1 R,IGFBP3 protein expression using immunohistochemical methods. Results: Squamous cell lung cancer of IGF1 R positive expression rate was 54. 07%,higher than in adjacent normal tissue 32. 5%,squamous cell lung cancer of IGFBP3 positive expression rate was 61. 79%,lower than in adjacent normal tissue 87. 5%( P〈0. 05). IGF1 R expression was related with lymph node metastasis( P〈0. 05),IGFBP3 expression was related with the TNM stage,lymph node metastasis( P〈0. 01),and had relation to smoking,gender,age. IGF1 R expression-positive patient overrall survival ratio was shorter than the expression-negative of IGF1 R,IGFBP3 expression-positive patient overrall survival ratio was longer than the expression-negative of IGFBP3. Cox regression univariate analysis showed that the squamous cell lung cancer prognosis was related with the TNM stage,lymph node metastasis,the expression of IGF1 R and IGFBP3. Cox regression analysis of multi factors showed that the squamous cell lung cancer prognosis was related with the TNM stage,lymph node metastasis. The expression of IGF1 R and IGFBP3 was negatively correlated( r =-0. 204,P〈0. 001). Conclusion: IGF1 R,IGFBP3 are involved in lung squamous cell carcinoma occurrence,development,and the two are the independent prognostic factors in squamous cell carcinoma of lung. And is expected to become a new target for molecular therapy.
出处 《现代肿瘤医学》 CAS 2015年第16期2313-2318,共6页 Journal of Modern Oncology
关键词 IGF1R IGFBP3 肺鳞癌 IGF1R IGFBP3 SQCLC
  • 相关文献

参考文献19

  • 1Siegel R,Naishadham D,Jemal A.Cancer statistics[J].CA Cancer J Clin,2012,62(1):10-29. 被引量:1
  • 2Li T,Kung HJ,Mack PC,et al.Genotyping and genomic profiling of non-small-cell lung cancer:implications for current and future therapies[J].J Clin Oncol,2013,31(8):1039-1049. 被引量:1
  • 3LeRoith D,Roberts CT Jr.The insulin-like growth factor system and cancer[J].Cancer Lett,2003,195(2):127-137. 被引量:1
  • 4Firth SM,Baxter RC.Cellular actions of the insulin-like growth factor binding proteins[J].Endocr Rev,2002,23(6):824-854. 被引量:1
  • 5Jones JI,Clemmons DR.Insulin-like growth factors and their binding proteins:biological actions[J].Endocr Rev,1995,16(1):3-34. 被引量:1
  • 6Nakagawa M,Uramoto H,Oka S,et al.Clinical significance of IGF1R expression in non-small-cell lung cancer[J].Clin Lung Cancer,2012,13(2):136-142. 被引量:1
  • 7Kathy Gately,Lydia Forde,Sinead Cuffe,et al.High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected none small-cell lung cancer[J].Clin Lung Cancer,2014,15(1):58-66. 被引量:1
  • 8Tran TN,Selinger CI,Yu B,et al.Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer[J].J Clin Pathol,2014,67(11):985-991. 被引量:1
  • 9Kikuchi R,Sonobe M,Kobayashi M,et al.Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma[J].Ann Surg Oncol,2012,Suppl(3):S412-20. 被引量:1
  • 10Yamamoto T,Oshima T,Yoshihara K,et al.Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer[J].Exp Ther Med,2012,3(5):797-802. 被引量:1

二级参考文献62

  • 1王言奎,崔娜,李军,罗兵.子宫内膜癌组织中垂体肿瘤转化基因PTTG的表达及其意义[J].中华妇产科杂志,2004,39(8):538-542. 被引量:11
  • 2Sangai T,Fujimoto H,Miyamoto S,et al.Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice[J].Clin Exp Metastasis,2008,25(4):401-410. 被引量:1
  • 3Tang X,Zhang Q,Shi S,et al.Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells[J].Int J Cancer,2010,126(1):90-103. 被引量:1
  • 4Gooch JL,Van Den Berg CL,Yee D.Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death-proliferative and anti-apoptotic effects[J].Breast Cancer Res Treat,1999,56(1):1-10. 被引量:1
  • 5Dunn SE,Hardman RA,Kari FW,et al.Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs[J].Cancer Res,1997,57(13):2687-2693. 被引量:1
  • 6Lu Y,Zi X,Pollak M.Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells[J].Int J Cancer,2004,108(3):334-341. 被引量:1
  • 7Szepeshazi K,Schally AV,Armatis P,et al.Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth[J].Endocrinology,2001,142(10):4371-4378. 被引量:1
  • 8Kahán Z,Varga JL,Schally AV,et al.Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice[J].Breast Cancer Res Treat,2000,60(1):71-79. 被引量:1
  • 9Friend KE.Cancer and the potential place for growth hormone receptor antagonist therapy[J].Growth Horm IGF Res,2001,11(Suppl A):S121-123. 被引量:1
  • 10Ingle JN,Suman VJ,Kardinal CG,et al.A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma[J].Cancer,1999,85(6):1284-1292. 被引量:1

共引文献14

同被引文献28

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部